Search research articles
Contact Us
Filters
Showing results (31-40 of 41) with videos related to
Page
of 5
Sort By:
BMJ Open
|
January 9, 2020
LIFEStyle, Prevention and Risk of Acute PaNcreatitis (LIFESPAN): protocol of a multicentre and multinational observational case-control study
Balázs Koncz, Erika Darvasi, Dalma Erdősi, et al.
BMJ Open
|
July 11, 2019
Endoscopic sphincterotoMy for delayIng choLecystectomy in mild acute biliarY pancreatitis (EMILY study): protocol of a multicentre randomised clinical trial
Levente Pál Kucserik, Katalin Márta, Áron Vincze, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2017
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Manfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
John Bridgewater, Peter Fletcher, Daniel H Palmer, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 7, 2020
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club
William Greenhalf, Philippe Lévy, Thomas Gress, et al.
Pancreas
|
March 22, 2024
Interventions for Pancreatitis-New Approaches, Knowledge Gaps, and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop
Anna Evans Phillips, Steven J Hughes, Dana K Andersen, et al.
The Lancet. Oncology
|
June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton, Paul Silcocks, Trevor Cox, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2014
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Franck Bonnetain, Bert Bonsing, Thierry Conroy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 14, 2021
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis
Robert A Moran, Christopher Halloran, Qiang Guo, et al.
International Journal of Cancer
|
December 1, 2022
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk
Matteo Giaccherini, Riccardo Farinella, Manuel Gentiluomo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 41) with videos related to
Sort By:
Page
of 5
BMJ Open
|
January 9, 2020
LIFEStyle, Prevention and Risk of Acute PaNcreatitis (LIFESPAN): protocol of a multicentre and multinational observational case-control study
Balázs Koncz, Erika Darvasi, Dalma Erdősi, et al.
BMJ Open
|
July 11, 2019
Endoscopic sphincterotoMy for delayIng choLecystectomy in mild acute biliarY pancreatitis (EMILY study): protocol of a multicentre randomised clinical trial
Levente Pál Kucserik, Katalin Márta, Áron Vincze, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 2, 2017
3rd St. Gallen EORTC Gastrointestinal Cancer Conference: Consensus recommendations on controversial issues in the primary treatment of pancreatic cancer
Manfred P Lutz, John R Zalcberg, Michel Ducreux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 22, 2022
Long-Term Outcomes and Exploratory Analyses of the Randomized Phase III BILCAP Study
John Bridgewater, Peter Fletcher, Daniel H Palmer, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
July 7, 2020
International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the International Association of Pancreatology, the American Pancreatic Association, the Japan Pancreas Society, and European Pancreatic Club
William Greenhalf, Philippe Lévy, Thomas Gress, et al.
Pancreas
|
March 22, 2024
Interventions for Pancreatitis-New Approaches, Knowledge Gaps, and Research Opportunities: Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop
Anna Evans Phillips, Steven J Hughes, Dana K Andersen, et al.
The Lancet. Oncology
|
June 24, 2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial
Gary Middleton, Paul Silcocks, Trevor Cox, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 27, 2014
Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials)
Franck Bonnetain, Bert Bonsing, Thierry Conroy, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]
|
November 14, 2021
Early infection is an independent risk factor for increased mortality in patients with culture-confirmed infected pancreatic necrosis
Robert A Moran, Christopher Halloran, Qiang Guo, et al.
International Journal of Cancer
|
December 1, 2022
Association between a polymorphic variant in the CDKN2B-AS1/ANRIL gene and pancreatic cancer risk
Matteo Giaccherini, Riccardo Farinella, Manuel Gentiluomo, et al.
Page
of 5